cagrilintide semaglutide cagrisema phase 3 results 2024 2025 CagriSema: Results, Dosing, Side Effects & 2026 FDA Update CagriSema vs Retatrutide 2026: Approval

Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms

Compared to other anti-obesity drugs, GLP-1 RAs have other demonstrable benefits such as cardioprotective and renoprotective qualities and fewer known side effects

Understanding individual biomarkers and genetic predisposition may help providers anticipate and mitigate this side effect

doi: 10.1016/j.molmet.2019.08.013 48 HyerKLHgildMLListEOLeeKYKissingerESharmaRet al

"Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes." Obesity Reviews 20.9 (2019): 1205-1217

New to the market is the oral Wegovy pill, an ideal option for those preferring tablets over injections